Teligent is a specialty generic pharmaceutical company (NASDAQ: TLGT). Our mission is to be a leading player in the specialty generic prescription drug market.

We sell a portfolio of prescription topical medicines and a growing number of hospital-based sterile injectable products, including cephalosporins.

Recent News

Teligent to Pursue Asset Sale through Voluntary Chapter 11 Process

Company is arranging $12 million debtor-in-possession financing from its senior secured lenders and access to its cash c...

Learn More

Teligent, Inc. Announces Second Quarter 2021 Earnings Report and Provides Business Update

– Update on FDA Inspection of Buena Facility – Assessing New Growth Opportunities in Injectables – Conference Call to Be...

Learn More

Teligent, Inc. to Hold Conference Call for Second Quarter 2021 Financial Results on Monday, August 16, 2021

BUENA, N.J. , Aug. 11, 2021 (GLOBE NEWSWIRE) -- Teligent , Inc. (Nasdaq: TLGT), ("Teligent" or the "Company"), a New Jer...

Learn More


Investor Overview

There are no items to display.

Stock Information

Data Provided by Refinitiv. Minimum 15 minutes delayed.